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ABSTRACT
G protein-coupled receptor signaling does not result from
sequential activation of a linear pathway of proteins/enzymes,
but rather from complex interactions of multiple, branched
signaling routes, i.e., signaling networks. In this work we present
an exhaustive study of the cross-talk between H1 and H2
histamine receptors (H1R and H2R) in U937 cells and Chinese
hamster ovary-transfected cells. By desensitization assays we
demonstrated the existence of a crossdesensitization between
both receptors independent of protein kinase A or C. H1R-
agonist stimulation inhibited cell proliferation and induced
apoptosis in U937 cells following treatment of 48 hours. H1R-
induced antiproliferative and apoptotic response was inhib-
ited by an H2R agonist suggesting that the cross-talk between
both receptors modifies their function. Binding and confocal
microscopy studies revealed cointernalization of both receptors
upon treatment with the agonists. To evaluate potential het-
erodimerization of the receptors, sensitized emission fluores-
cence resonance energy transfer experiments were performed in
human embryonic kidney 293T cells using H1R-cyan fluorescent
protein and H2R-yellow fluorescent protein. To our knowledge
these findings may represent the first demonstration of agonist-
induced heterodimerization of the H1R and H2R. In addition,
we also show that the inhibition of the internalization pro-
cess did not prevent receptor crossdesensitization, which was
mediated by G protein-coupled receptor kinase 2. Our study
provides new insights into the complex signaling network
mediated by histamine and further knowledge for the rational
use of its ligands.
Introduction
Histamine [2-(4-imidazolyl)-ethylamine] is an important
mediator of many physiologic and pathologic processes,
including inflammation, gastric acid secretion, neuromodula-
tion, regulation of immune function, and cell proliferation and
differentiation. Histamine exerts its effects by binding to four
different G protein-coupled receptors (GPCRs), namely his-
tamine receptors 1, 2, 3, and 4 (H1R, H2R, H3R, H4R) (Parsons
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ABBREVIATIONS: AC, adenyl cyclase; amthamine, 5-(2-aminoethyl)-4-methyl-1,3-thiazol-2-amine; BSA, bovine serum albumin; [Ca21]i,
intracellular Ca21; CFP, cyan fluorescent protein; CHO, Chinese hamster ovary; CHO-H1R, CHO-K1 cells stably expressing human H1R; CHO-
H2R, CHO-K1 cells stably expressing human H2R; CHO-H1R-H2R, CHO-H1R cells expressing human H2R; DMEM, Dulbecco’s modified Eagle’s
medium; forskolin, (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-3-vinyldodecahydro-1H-benzo[f]
chromen-5-yl acetate; FRET, fluorescence resonance energy transfer; gentamicin, (3R,4R,5R)-2-{[(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,6S)-
3-amino-6-[(1R)-1-(methylamino)ethyl]oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol; GF109203X, 2-[1-(3-
dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)maleimide; GPCR, G protein-coupled receptor; GRKs, G protein-coupled receptor kinases;
H1R, histamine receptor 1; H2R, histamine receptor 2; histamine, [2-(4-imidazolyl)-ethylamine]; HEK293T, human embryonic kidney 293T cells;
hypoxanthine, 1H-purin-6(9H)-one; IBMX, isobutylmethyl xanthine (1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione); InsP, inositol phosphates;
isoproterenol, (RS)-4-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol; KT5720, (5R,6S,8S)-hexyl 6-hydroxy-5-methyl-13-oxo-6,7,8,13,
14,15-hexahydro-5H-16-oxa-4b,8a,14-triaza-5,8-methanodibenzo[b,h]cycloocta[jkl]cyclopenta[e]-as-indacene-6-carboxylate; mepyramine,
N-(4-methoxybenzyl)-N9,N9-dimethyl-N-pyridin-2-ylethane-1,2-diamine; myoinositol, 1,2,3,4,5,6-hexahydroxycyclohexane; PARP, poly-(ADP-
ribose)-polymerase; PBS, phosphate buffered saline; PGE2, prostaglandin E2 [(5Z,11a,13E,15S)-7-[3-hydroxy-2-(3-hydroxyoct-1-enyl)- 5-oxo-
cyclopentyl] hept-5-enoic acid]; PI, propidium iodide; PKA, protein kinase A; PKC, protein kinase C; PLC, phosphoinositide-specific
phospholipase C; RH, regulator of G protein signaling (RGS)-homology domain; U73122, 1-[6-[[(17b)-3-methoxyestra-1,3,5(10)-trien-17-yl]
amino]hexyl]-1H-pyrrole-2,5-dione; YFP, yellow fluorescent protein.
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and Ganellin, 2006). Particularly, the H1R and H2R have
been found to be coexpressed in most tissues and cell types
such as neurons, airway, and vascular smooth muscle cells,
endothelial cells, hepatocytes, epithelial cells, neutrophils,
eosinophils, monocytes, dendritic cells, as well as T and
B lymphocytes among others (Parsons and Ganellin, 2006;
Jutel et al., 2009). In most tissues, H1R couples to Gaq/11
leading to the increase in phosphoinositide metabolism,
whereas H2R couples to Gas, triggering adenylyl cyclase
(AC) activation and cAMP accumulation (Hill et al., 1997).
Several studies support a coordinated regulation between
both receptors. For example, in guinea pig cerebral cortical
slices, H1R stimulation augments cAMP responses to H2R
stimulation via a mechanism which appears to involve the
accumulation of inositol triphosphate and diacylglycerol
(Selbie and Hill, 1998). In contrast, a reverse interaction can
occur in bovine tracheal smooth muscle in which agents
raising intracellular cAMP levels can inhibit H1R-mediated
inositol phospholipid hydrolysis (Dickenson et al., 1993). In
this case, the application of selective H1- and H2-receptor
agonists and antagonists in the lung established the concept
that the two receptor populations may mediate opposing
physiologic and pharmacological effects in the pulmonary
system. H1R mediates deleterious actions such as broncho-
constriction, vasoconstriction, and edema formation, while
stimulation of pulmonary H2R plays amodulatory role, causing
bronchodilation and inhibiting mediator release (Parsons and
Ganellin, 2006).
The activity of GPCRs results from a coordinated balance
among the diverse mechanisms that govern receptor signaling
at different levels of signal propagation; in this way the final
response of a cellular system results from the integration and
weighting up of the different signals it receives.
An important adaptive response of the cell against multiple
or sustained extracellular stimuli is receptor desensitization,
which protects the cell from receptor overstimulation. The
underlying mechanisms for turning off GPCR signalings are
complex and may involve receptor phosphorylation, uncou-
pling from G proteins, internalization, and ultimately re-
ceptor down-regulation (Zhang et al., 1997). In some cases, the
stimulation of one GPCR may lead to generalized desensiti-
zation of other unrelated GPCRs by a mechanism known as
heterologous desensitization (Ferguson, 2001). This process,
where nontargeted receptor signaling is inhibited by the
activation of a different receptor, would represent a regulatory
mechanism of coordination and balance of diverse signaling
cascades.
In this context, the discovery of GPCRs’ homo- and hetero-
oligomerization is revolutionizing the analysis of their phar-
macology and signaling integration, thus leading to renewed
interest in GPCRs as therapeutic targets and reinvigorat-
ing drug discovery and therapeutic strategies (Panetta and
Greenwood, 2008). Receptor oligomerization is essential for
receptor function in GABAB, taste and rhodopson receptors
that form heterodimers/oligomeric structures in native disk
membranes (Nelson et al., 2002; Filipek et al., 2004; Kniazeff
et al., 2004; Pin et al., 2004). Oligomerization has also been
shown to play a modulatory role. Furthermore, oligomeriza-
tion can be constitutive or agonist-induced, and its functional
relevance has been proved for many receptors (Breitwieser,
2004). In the case of H1R and H2R, both are known to be
coexpressed and they have been even described as multimeric
entities (Fukushima et al., 1997; Bakker et al., 2004). How-
ever, it is not known whether their coordinated regulation
is mediated by the formation of heteromeric H1/H2R com-
plexes. The purpose of the present work was to investigate the
potential cross-regulation between H1R and H2R in U937
cells, in which both histamine receptors are endogenously
expressed, and in Chinese hamster ovary (CHO)-transfected
cells. Our findings showed that in both cell types treatment
with H1R and H2R agonists induce crossdesensitization of
both receptors by a mechanism independent of second mes-
senger systems and their downstream kinases, kinases A
(PKA) or C (PKC). Furthermore, the H1R agonist inhib-
ited cell proliferation and induced apoptosis in U937 cells.
Interestingly, when cells were exposed to both H1R and
H2R agonists these responses were abolished. In trans-
fected cells, colocalization and fluorescence resonance energy
transfer (FRET) microscopy assays revealed the cointernal-
ization of the receptors with the formation of heteromers in
endosomes upon their activation. In addition, we also show
that the inhibition of the internalization process did not
prevent receptor crossdesensitization, which was mediated
by GRK2.
These results indicate that there is a negative cross-
regulation mechanism betweenH1 andH2 receptors, involving
crossdesensitization, cointernalization, and heterodimeriza-
tion, which is critical for the output response to histaminergic
stimulation.
Materials and Methods
Materials
Cell culture medium, antibiotics, isobutylmethyl xanthine (IBMX),
cAMP, prostaglandin E2 (PGE2), ATP, isoproterenol, histamine,
forskolin, 2,3-trifluoromethylphenylhistamine (H1R agonist), myoino-
sitol, bovine serum albumin (BSA), phosphoinositide-specific phospho-
lipase C (PLC) inhibitor U73122, PKC inhibitor GF109203X, and PKA
inhibitor KT5720 were obtained from Sigma Chemical Company (St.
Louis, MO). Amthamine (H2R agonist), mepyramine, and tiotidine
were acquired fromTocris Cookson Inc. (R&DSystems Inc.,Minneapolis,
MN). [3H]cAMP, [3H]mepyramine, [3H]tiotidine, and myo-[3H]inositol
were purchased from Perkin Elmer Life Sciences (Boston, MA). Dowex
AG-1X8 formate form resin was obtained from Bio-Rad (Hercules,
CA). Other chemicals used were of analytical grade and obtained from
standard sources.
Generation of cDNA Constructs
H2R-yellow fluorescent protein (-YFP) and H1R-cyan fluorescent
protein (-CFP). To create expression plasmids encoding fusion proteins,
the wild-type human H2R cDNA was amplified from pCEFL-H2R with
a sense primer (59GTAGAATTCCACCATGGCACCCAATGG39) and an
antisense primer (59CGGGATCCTTCCTGTCTGTGG39) and inserted
into the EcoRI/BamHI sites of pEYFP-N1 (Clontech, Mountain View,
CA). The wild-type human H1R cDNA was amplified from pCDNA3-
H1Rwith a sense primer (59GCTAGCACCATGAGCCTCCTA39) and an
antisense primer (59GGCAAGCTTGGAGCGAATATGCAGAATTCTC-
T39) and inserted into the NheI/HindIII sites of pECFP-N1 (Clontech).
Cell Culture and Transfections
U937 cells and derived clones (A2, DC6, and GB4) were cultured at
37°C in a humidified atmosphere of 5% CO2 in RPMI 1640 medium,
CHO-H1R, CHO-H2R, and CHO-H1R-H2R cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 100
mM hypoxanthine, 16 mM thymidine, 0.8 mg/ml G418, and human
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embryonic kidney (HEK)293T were cultured in DMEM; all supple-
mented with 10% fetal calf serum and 5 mg/ml gentamicin. The stably
expressing humanH1R andH2R cell lines (CHO-H1R and CHO-H2R)
were previously generated in our laboratory (Notcovich et al., 2010;
Tubio et al., 2010). DC6, A2, and GB4 cell lines were obtained by U937
stable transfection with a dynamin dominant negative mutant, a G
protein-coupled receptor kinase 2 (GRK2) antisense construct, and
a GRK2 dominant negative mutant of the kinase site, and were
previously characterized (Fernandez et al., 2002, 2008, 2011).
For transient transfection, cells were grown to 80–90% confluency
and the cDNA constructs were transfected using LipofectAMINE
2000. The transfection protocol was optimized as recommended by the
supplier (Invitrogen, Carlsbad, CA). Usually, assays were performed
48 hours after transfection.
cAMP Assay
For desensitization assays, cells were pretreated with agonists,
antagonists, and/or inhibitors in the absence of IBMX at the times
shown in the figures. Cells were then washed and resuspended in
fresh medium containing 1 mM IBMX, incubated for 3 minutes, and
exposed to 10 mMamthamine, 1 mM isoproterenol, or 1 mMPGE2 for 9
minutes to determine whether the systemwas able to generate cAMP.
The reaction was stopped by ethanol addition followed by centrifu-
gation at 2000g for 5 minutes. The ethanol phase was then dried and
the residue resuspended in 50 mM Tris-HCl, pH 7.4, 0.1% BSA.
cAMP content was determined by competition of [3H]cAMP for PKA,
as previously described (Davio et al., 1995).
[3H]-Inositol Phosphate Production
Total inositol phosphate production was assessed as previously
described (Fitzsimons et al., 2004). Briefly, cells were incubated with
myo-[3H]-inositol (5 mCi/ml) in DMEMwith calf serum and cultured for
6 hours. Thereafter, the medium was replaced by DMEM without calf
serum containing 10mMLiCl and incubated for 10minutes. Cells were
pretreated 5 minutes with the different agonists and/or antagonists,
washed, and cells were then stimulated for 20 minutes with H1R
agonist or ATP in a final volume of 300 ml. In assays in the presence of
inhibitor, PKA inhibitor was added 20 minutes before the agonist
stimulation. The reaction was stopped by the addition of 2 ml of cold
chloroform/methanol (1:2 v/v, freshly prepared), and phases were
separated by adding 1 ml of water and 620 ml of chloroform. The
mixture was then centrifuged at 1500g for 10 minutes, and the total
water-soluble inositol phosphate fraction was purified by anion
exchange chromatography. Radioactivity in the eluted fractions was
measured using a Wallac 1410 liquid scintillation counter.
Intracellular Ca21 Measurements
Intracellular Ca21 measurement was assessed as previously de-
scribed (Copsel et al., 2011). Briefly, U937 cells were resuspended and
incubated in a buffered saline solution (BSS: 140 mM NaCl, 3.9 mM
KCl, 0.7 mMKH2PO4, 0.5 mMNa2HPO4. 12H2O, 1 mMCaCl2, 0.5 mM
MgCl2 and 20 mM HEPES, 10 mM glucose, and 0.1% BSA, pH 7.5) in
the presence of 2 mM Fura 2-AM for 30 minutes. Fluorescence was
measured in a spectrofluorometer (Jasco, Tokyo, Japan) provided with
theCA-61 accessory to measure Ca21with continuous stirring, with the
thermostat adjusted to 37°C and an injection chamber. During 8
minutes intracellular Ca21 ([Ca21]i) levels were registered every second
by exposure to alternating 340- and 380-nm light beams, and the
intensity of light emission at 505 nm was measured. In this way, light
intensities and their ratio (F340/F380) were tracked. Different agents
were injected into the chamber as a 100-fold concentrated solution
without interrupting recording. The preparation was calibrated by
determining maximal fluorescence induced by 0.1% Triton X-100, and
minimal fluorescence in the presence of 6 mM EGTA (pH 8.3). [Ca21]i
was calculated according to Grynkiewicz et al., 1985.
Cell Proliferation
U937 cells were seeded at 2  105 cells/ml and incubated for 1 or 2
days with different combinations of compounds. Cells were harvested,
and their numbers were estimated using a hemocytometer chamber.
Determination of Apoptosis Markers
Cell Cycle Analysis. U937 cells growing in exponential phase
were treated as indicated for 48 hours. Then, cells were harvested and
centrifuged at 1000 rpm for 5 minutes, resuspended in one volume
of phosphate buffered saline (PBS) and fixed and permeabilized by
vigorous addition of nine volumes of ice-cold 70% (v/v) ethanol and
stored at –20°C for a minimum of 24 hours, prior to analysis. Cells
at a density of approximately 106 were resuspended in 800 ml of
propidium iodide (PI) staining solution (20 mg/ml PI and 200 mg/ml
RNase A in PBS, pH 7.4) and incubated in the dark at room
temperature for 30 minutes. The percentages of cells in the sub-G0/
G1, G0/G1, S, and G2/M cell cycle phases were determined by a FACS
Scan Flow Cytometer (Becton-Dickinson, Laguna Hills, CA). Data
from at least three independent experiments were analyzed using
Cyflogic free software (www.cyflogic.com).
Determination of Phosphatidylserine Exposure at the Cell
Surface by Annexin V Binding Assay. Cells growing in exponen-
tial phase were seeded at 3.5  105 cells/ml and treated with different
compounds or 2% (v/v) dimethylsulfoxide (DMSO; positive control) for
48 hours. Following cold PBS washing, 2.0  105 cells were incubated
with fluorescein isothiocyanate (FITC)-labeled annexin V and PI
according to the manufacturer instructions (Invitrogen) and analyzed
using a FACS Scan Flow Cytometer (Becton-Dickinson). The different
cell subpopulations were identified according to the annexin V/PI
staining pattern, as follows: cells labeled with annexin V only were
considered to be at an early apoptotic stage, cells labeled with annexin
V and PI were considered to be at a late apoptotic stage, and cells
labeled with PI only were considered necrotic.
Determination of Caspase-3, and Poly(ADP-Ribose)Polymerase
by Western Blot. For Western blot assays cells were lysed in 50 mM
Tris-HCl, pH 6.8, 2% SDS, 100 mM 2-mercaptoethanol, 10% glyc-
erol, and 0.05% bromophenol blue and sonicated to shear DNA.
Total cell lysates were resolved by 8% SDS-PAGE for poly(ADP-
ribose)polymerase (PARP) detection or 15% SDS PAGE for caspase 3
detection, blotted, and incubated with the indicated primary anti-
bodies (Santa Cruz Biotechnology, Dallas, TX), followed by horserad-
ish peroxidase conjugated anti-rabbit (Santa Cruz Biotechnology),
and developed by enhanced chemiluminesence (ECL) following the
manufacturer’s instructions (Amersham, GE Healthcare Lifesciences,
Pittsburgh, PA).
Radioligand Binding Assay. Triplicate assays were performed
in 50 mM Tris-HCl, pH 7.4. Saturation studies were performed by
incubating 106 U937 cells/tube or 104 CHO-H1R, CHO-H2R, or CHO-
H1R-H2R cells per 48 wells for 40 minutes at 4°C with increasing
concentrations of [3H]tiotidine or [3H]mepyramine, ranging from 0.4 up
to 240 nM in the absence or presence of 1 mM unlabeled tiotidine or
mepyramine, respectively. The incubation was stopped by dilution with
3 ml of ice-cold 50 mM Tris-HCl, pH 7.4. For U937 cells, rapid filtra-
tion under reduced pressure onto Whatman GF/B glass-fiber filters,
followed by three washes with 3 ml ice-cold buffer was performed. For
CHO-transfected cells, after three washes with 3 ml ice-cold buffer the
bound fraction was collected in 200 ml of ethanol. Experiments on intact
cells were carried out at 4°C to avoid ligand internalization. The kinetic
studies performed with 2 nM [3H]tiotidine or [3H]mepyramine at 4°C
showed that the equilibrium was reached at 30 minutes and persisted
for 4 hours (unpublished data).
Confocal Microscopy. HEK293T cells were grown to 80–90%
confluency in p35 glass-bottom dishes (MatTek, Ashland, MA) and
transfected with the corresponding plasmids using Lipofect-
AMINE 2000 reagent (Invitrogen). Assays were performed after
48 hours and cells were serum-starved for 2 hours prior stim-
ulation. Live cell imaging was performed using a LSM 700 Zeiss
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confocal laser-scanning microscope with a Plan-Apochromat 63
1.40 NA oil immersion objective and incubation at 37°C and 5%
CO2. Cells were stimulated with 10 mM H1R or H2R agonist
and images were acquired every 1–2 minutes over a period of
30 minutes. Excitation and filters were as follows: CFP, 445 nm
excitation, band-pass (BP) 460–500-nm emission; YFP, 488 nm
excitation, BP 520–600-nm emission. The image and statistical
analysis was performed with the ImageJ software Colocalization
Analysis plugin (NIH, Bethesda, MD).
FRET Measured by Confocal Microscopy. HEK293T cells
were grown and stimulated with H1R and H2R agonist as described
before. To normalize FRET, the background given by the images from
nontransfected cells was subtracted from the images from transfected
cells, and the resulting images were processed by the FRET and
Colocalization Analyzer plugin of ImageJ software. This software
allows visualization of FRET images acquired by confocal sensitized
emission, involving excitation of the donor fluorophore and detection
of the energy transfer as an emission from the acceptor fluorophore
into the FRET channel. The plugin calculates the Bleed-Through of
the pair of fluorophores as constant values and substract them from
the raw FRET channel Image using an equation similar to the one
described in Youvan et al., 1997. This method reduces the interference
of the user to aminimumby analyzing the entire image, pixel by pixel,
and displays FRET images as a function of the colocalization of the
two fluorescent partners.
Statistical Analysis. Statistical analysis was performed from at
least three independent experiments. Binding data, sigmoidal dose-
response, and desensitization fittings were performed with GraphPad
Prism 5.00 for Windows, GraphPad Software (San Diego, CA). One-
way ANOVA followed by Dunnett’s post test was performed using
GraphPad InStat version 3.01 (GraphPad Software). Specific binding
was calculated by subtraction of nonspecific binding from total
binding. Cellular proliferation and cell cycle statistical analysis were
carried out by one-way ANOVA followed by Tukey’s multiple com-
parison post test.
Results
H1R and H2R Crossdesensitization. To evaluate the
potential cross-regulation between H1 and H2 receptors we
studied in U937 and in CHO-transfected cells the effect of
10 mM 2,3-trifluoromethylphenylhistamine (H1R agonist)
pretreatment on H2R response and the effect of 10 mM
amthamine (H2R agonist) pretreatment on H1R response.
Cyclic AMP production following 10 mM H2R agonist stimu-
lation decreased in U937 cells pretreated with H1R agonist at
different time periods, whereas the response to 1 mM iso-
proterenol (b-adrenoreceptor agonist) was unaffected (Fig. 1A).
The concentration used for each ligand corresponded to the
maximum cAMP response in U937 cells (unpublished data).
Furthermore, this crossdesensitization was abolished by
10 mM mepyramine (H1R antagonist), supporting that the
response was mediated by H1R activation (Fig. 1B). To
evaluate whether this effect resulted from modulation by
second messengers, H1R response was evaluated following
activation of another Gq-coupled receptor. Results showed
that cAMP response to amthamine in ATP (purinergic-
recepter agonist)-pretreated cells remained unchanged (Fig.
1B).We next addressed whether the cross-regulation observed
in U937 was privative of this cell line by using CHO cells
which do not express H1R or H2R membrane sites, as
revealed by binding assays or the response to H1R or H2R
agonists (unpublished data). We generated stably expressing
human H1R CHO cells (CHO-H1R) (Notcovich et al., 2010)
transiently transfected with H2R. In this model, amthamine
but not PGE2 response was desensitized by pretreatment with
10 mM H1R agonist, in accordance with observations in U937
cells (Fig. 1C). To confirm that H1R agonist desensitized H2R
response through H1R, the assay was performed in H2R-
expressing CHO-H2R cells, which were previously character-
ized in our laboratory (Tubio et al., 2010). As shown in Fig. 1D,
no crossdesensitization occurs in the absence of H1R. These
findings clearly show that H1R stimulation induces cross-
desensitization of the H2R response when endogenously ex-
pressed in U937 and in reconstituted CHO-H1R-H2R cells.
We next investigated whether H2R agonist induced cross-
desensitization of H1R. As shown in Fig. 2, A and B, pre-
treatment of U937 cells with 10 mM H2R agonist decreased
InsP production and Ca21 accumulation in response to H1R
stimulation. We then evaluated if H2R crossdesensitized H1R
response. As shown in Fig. 2, A and B, U937 cells pretreated
with 10 mMH2R agonist decreased InsP production and Ca21
accumulation in response to H1R stimulation. This negative
cross-talk was not evident when cells were pretreated with
other ligands that increase cAMP levels, such as PGE2,
isoproterenol, or forskolin (AC activator), and was inhibited
by the H2R antagonist tiotidine. In CHO-H1R-H2R-transfected
cells, pretreatmentwith theH2Ragonist desensitized InsP-H1R
response but not ATP response. Furthermore, in CHO-H1R
Fig. 1. Effect of H1R agonist on H2R response. (A and C) H2R desen-
sitization kinetic induced by 2,3-trifluoromethylphenylhistamine (H1R
agonist). U937 (A) or CHO-H1R-H2R (C) cells were incubated with 10 mM
H1R agonist at different time points and washed twice with PBS. cAMP
response to 10 mM amthamine (H2R agonist), 1 mM isoproterenol, or 1 mM
PGE2 was determined as detailed under Materials and Methods. Data
represent mean 6 S.E.M. (n = 3). ***P , 0.001 with respect to initial
response. (B) U937 cells were exposed to 10 mM H1R agonist, 10 mM
mepyramine, or 1 mM ATP, alone or in combination for 30 minutes,
washed twice with PBS, and cAMP response to 10 mM amthamine
determined (shaded bars). Data represent mean 6 S.E.M. (n = 3). ***P ,
0.001; ###P , 0.001 respect to H1R agonist pretreatment. (D) CHO-H2R
cells were exposed to 10 mMH1 agonist for 30 minutes, washed, and cAMP
response to 10 mM amthamine determined (shaded bars). Data represent
mean 6 S.E.M. (n = 3). cAMP basal levels were not significantly modified
by H1R agonist preincubation.
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cells crossdesensitization was not detected in the absence of
H2R (Fig. 2D).
Our findings demonstrate the existence of a specific and
mutual crossdesensitization between H1R and H2R in two
different cell lines.
For a large number of relatedGPCRs, activation of oneGPCR
induces phosphorylation of C-terminal cytosolic tails of another
GPCR by second messenger-mediated kinases, such as PKA or
PKC. Phosphorylated receptors lose their capacity to couple to
the downstream heterotrimeric G protein and therefore become
insensitive to stimulation. With the aim to determine whether
PKA and PKC was responsible for the crossdesensitization of
H1RandH2R, assays inU937 cellswere performed in the presence
of pharmacological inhibitors of the kinases. As shown inFig. 3A,
GF109203X (PKC inhibitor) failed to modify the decrease in
H2R-mediated cAMP response induced by crossdesensitization.
In turn, KT5720 (PKA inhibitor) did not affect the negative
cross-talk in the H1R inositol phosphates (InsP) response (Fig.
3B). We also explored whether inositol 1,4,5 triphosphate and
1,2-diacylglycerol (DAG) generation resulting from phosphati-
dylinositol 4,5-biphosphate hydrolysis mediated by H1R agonist
was responsible for H2R desensitization. Fig. 3A shows that the
crossdesensitization also occurs in the presence of a PLC inhibitor.
Our findings show that H1R and H2R crossdesensitization
is independent of AC, PLC, PKA, and PKC activation.
H1Agonist-Induced Apoptosis in U937 Cells Is Inhibited
by an H2R Agonist. Histamine regulates cell proliferation
in different cell types through H1R activation (Lázár-Molnár
Fig. 2. Effect of H2R agonist on H1R response.
(A) U937 cells were exposed for 5 minutes to 10
mM H2R agonist, 1 mM PGE2, 1 mM isoprotere-
nol, 75 mM forskolin, or 10 mM tiotidine as
indicated, washed, and cells were then stimu-
lated for 20 minutes with 10 mM H1R agonist
(shaded bars). InsP production was measured as
described under Materials and Methods. Data
were calculated as the mean6 S.E.M. (n = 3). (B)
U937 cells were exposed for 5 minutes to 10 mM
H2R agonist, 1 mMPGE2, 1 mM isoproterenol, 75
mM forskolin, or 10 mM tiotidine as indicated and
stimulated with 10 mM H1R agonist. [Ca2+]i was
determined as described under Materials and
Methods. Data were calculated as the mean 6
S.E.M. (n = 3). ***P , 0.001; ###P , 0.001 with
respect to H2R agonist pretreatment. (C) CHO-
H1R-H2R cells were incubated with 10 mM H2R
agonist at different time points and washed. InsP
response to 10 mM H1 agonist or 1 mM ATP was
determined as detailed under Materials and
Methods. Data were calculated as the mean 6
S.E.M. (n = 3). ***P, 0.001 with respect to initial
response. (D) CHO-H1R cells were exposed to 10
mM H2R agonist for 30 minutes, washed, and
InsP response to 10 mM H1 agonist was de-
termined (shaded bars). Data were calculated
as the mean 6 S.E.M. (n = 3). InsP basal levels
were not significantly modify by H2R-agonist
preincubation.
Fig. 3. H1R and H2R crossdesensitization in
the presence of PLC/PKC and PKA inhibitors.
(A) U937 cells were exposed for 30 minutes to
10 mM H1R agonist, 10 mM U73122, or 20 mM
GF109203X as indicated, washed, and cAMP
response to 10 mM amthamine determined. (B)
U937 cells were exposed for 5 minutes to 10 mM
H2R agonist or 10 mM KT5720 as indicated
and washed, and cells were then stimulated
for 20 minutes with 10 mM H1R agonist. InsP
production was measured as described under
Materials and Methods. Data were calculated
as the mean6 S.E.M. (n = 3). ***P, 0.001 with
respect to untreated cells (control).
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et al., 2002; Notcovich et al., 2010). Exposure of U937 cells
to 10 mM H1R agonist for 48 hours inhibited cell prolifer-
ation by 56%, but the incubation with 10 mM H2R agonist
did not affect it (Fig. 4A). To evaluate whether H1R and
H2R crossdesensitization affected this response, cells were
incubated for 48 hours with the H1R agonist alone or in
combination with either H2R agonist or H1R antagonist
mepyramine. The antiproliferative effect mediated by H1R
was not only inhibited by H1R blockade (16%) but also by
H2R stimulation (21%). Pretreatment of cells with a PKA
inhibitor did not change H2R effect on H1R-mediated
response (Fig. 4B). FACS studies showed that U937 cells
incubated with the H1R agonist increased the number of
cells in the sub-G0/G1 phase of the cell cycle (Fig. 4C). When
cells were exposed to the H1R agonist and amthamine, cell
cycle arrest was not achieved in accordance with the
proliferative response observed. We next evaluated cleav-
age and activation of caspase 3, the key terminal effector of
apoptosis byWestern blot. The exposure of U937 cells to H1R
agonist increased caspase-3 cleavage. Furthermore, the
cleavage of caspase-3 downstream substrate and mediator
of cell death PARP was also observed following 48-hour cell
exposure to H1R agonist. However the activation of these
proapoptotic proteins was inhibited in the presence of the
H2R agonist (Fig. 4D). We also used annexin binding assay to
evaluate apoptosis. Following U937 cells’ exposure to the H1R
agonist, quantitative evaluation revealed a reduction in
normal cells with an increase in early and late apoptotic
subpopulations. The induction of apoptosis was blocked in
the presence of H2R agonist (Fig. 4E). The observation that
Fig. 4. Effect of H1R and H2R agonist on
U937 cell proliferation and apoptosis.
U937 cells were treated with 10 mM H1R
agonist, 10 mM mepyramine, 10 mM H2R
agonist, 10 mM KT5720, or 100 mM his-
tamine alone or in combination for 24 and
48 hours (A) or 48 hours (B–E). After
treatment, cell proliferation (A and B), cell
cycle stage (C), pro-caspase 3 and PARP
(D) and phosphatidylserine exposure at
the cell surface by annexin V binding were
evaluated as detailed in Materials and
Methods. (A) Data were calculated as the
means 6 S.D. of assay triplicates. Similar
results were obtained in at least three
independent experiments. ***P # 0.001
with respect to control cells. (B) Data
represent mean 6 S.E.M. (n = 3). ***P #
0.001 with respect control cells. 100%
corresponds to control cells. (C) Data were
calculated as the means 6 S.D. of assay
triplicates. Similar results were obtained
in at least three independent experi-
ments. **P # 0.01 with respect to control
cells. (D) Equal amounts of protein were
subjected to SDS-PAGE and analyzed by
Western blot with anti-caspase-3, anti-
PARP, and anti-tubulin antibodies. (E)
Different cell subpopulations according to
the annexin V/PI staining pattern: Cells
labeled with annexin V only were con-
sidered to be at an early apoptotic stage,
cells labeled with annexin V and PI were
considered to be at a late apoptotic stage,
and cells labeled with PI only were con-
sidered necrotic. Data were calculated
as the means 6 S.D. of assay triplicates.
Similar results were obtained in at least
three independent experiments. ***P #
0.001 respect to control cells.
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histamine failed to either inhibit cell proliferation or induce
apoptosis may be explained in terms of the dual stimulation
of both H1R and H2R by its natural ligand, leading to a sort
of “neutral effect.”
Our findings support that the cross-talk between H1R and
H2R not only modulates receptor signaling but also deter-
mines the resulting final response.
H1R and H2R Cointernalization. As the crossdesensi-
tization was independent not only of second messengers but
also of downstream second messenger-dependent protein
kinases, a possible cross-regulation at the receptor level was
evaluated. In a previous study performed in U937 cells endog-
enously expressing H2R as well as in COS7 and HEK293T
cells transiently expressing H2R, we reported that the re-
ceptor is internalized following histamine or H2R-agonist
stimulation as part of receptor trafficking (Fernandez et al.,
2008). Furthermore, H1R is also internalized following
histamine stimulation in H1R stably transfected CHO-K1
cells (Self et al., 2005; Hishinuma et al., 2010). Therefore
internalization studies were performed in U937 and CHO-
transfected cells to evaluate a putative reciprocal internal-
ization of H1R and H2R. U937 cells exposed to either H1R
or H2R agonist for 60 minutes showed membrane site in-
ternalization by 60% and 43%, respectively (Fig. 5A). Similar
results were obtained in CHO-H1R-H2R cells (Fig. 5B). The
H2R agonist failed to induce H1R internalization in CHO-
H1R cells. Furthermore, PGE2, which increases cAMP, also
failed to stimulate H1R internalization supporting the speci-
ficity of the cointernalization mechanism (Fig. 5B, right). In
both cell types, U937 and CHO-H1R-H2 cells, H2R was also
internalized following H2R stimulation (Fig. 5, C and D). In
addition, H2R internalization did not occur in the absence of
H1R in CHO-H2R cells or upon ATP stimulation as a control
(Fig. 5D, right). These findings reveal a specific cross-regulation
betweenH1R andH2R at the receptor level mediated by agonist-
induced receptor cointernalization
In an attempt to confirm these results, studies by confocal
microscopy on HEK293T living cells were performed. Wild-
type receptors were subcloned into pECFP-N1 and pEYFP-N1
vectors to obtain H1R-CFP and H2R-YFP, respectively.
Binding assays were performed to evaluate the expression
and internalization of the chimeric receptor (unpublished
data). To visualize cointernalization, cells were transfected
with both chimeric receptors, serum starved, and stimu-
lated by 10 mM H1R agonist (Fig. 6A) or 10 mM H2R agonist
(Fig. 6B). Ligand-induced internalization was monitored for
30 minutes. Images from three different experiments were
analyzed with the plugin Colocalization Analyzer of ImageJ
Fig. 5. Cointernalization of H1R and H2R. (A and C) [3H]Mepyramine (A) or [3H]tiotidine (C) saturation assays were performed in U937 cells: control
(j), treated with 10 mM H2R agonist (s), or 10 mM H1R agonist (d) for 60 minutes. Data were calculated as the means 6 S.D. of assay triplicates.
Similar results were obtained in at least three independent experiments. (B and D) Left: [3H]mepyramine (B) or [3H]tiotidine (D) saturation assays were
performed in CHO-H1R-H2R cells: control (j), treated with 10 mMH2R agonist (s), or 10 mMH1R agonist (d) for 60 minutes. Data were calculated as
the means 6 S.D. of assay triplicates. Similar results were obtained in at least three independent experiments. Right: Data represent the percentage
Bmax value fitted by nonlinear regression of saturation assay, performed in CHO-H1R-H2R and CHO-H1R (B) or CHO-H1R-H2R and CHO-H2R cells (D)
control, treated with 10 mMH1R agonist, 10 mMH2R agonist, 1 mMPGE2, or 1 mMATP, calculated as the means6 S.E.M. (n = 3). 100% corresponds to
untreated cells (control). ***P , 0.001; **P , 0.01 respect to control cells.
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and representative pseudo-color images are shown. Cellular
distribution analysis of the two receptors revealed partial
colocalization in the plasma membrane before stimulation;
mean Manders’ coefficients m1 (proportion of green signal
that colocalize) and m2 (proportion of red signal that
colocalize) were 0.597 and 0.582, respectively. As shown in
Fig. 6, in the absence of agonist stimulation cells exhibited
a basal receptor internalization due to the receptors over-
Fig. 6. Kinetics of ligand-induced H1R-CFP and
H2R-YFP internalization. The cellular distribution
of H1R-CFP (green) coexpressed with H2R-YFP
(red) in HEK293T cells was videorecorded and dis-
played on a single confocal plane before (0 minutes)
and following (5, 10, and 20 minutes) stimulation
with 10 mM H1R agonist (A) or 10 mM H2R agonist
(B). The corresponding colocalized points (H1R-
H2R, white) are shown (Merge). Inset shows higher
magnification of the area, arrows indicate intracel-
lular endocytic vesicles. These images are repre-
sentative of three independent experiments. Scale
bars, 10 mM.
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expression and their constitute activity, but colocalization is
visualized only in the plasma membrane.
After 5 minutes treatment with H1R or H2R agonists,
receptor cointernalization was observed as small bright spots
within the cell, a characteristic distribution of receptors lo-
cated in intracellular endocytic vesicles. The vesicular pattern
reached a maximum of intensity at 10 minutes treatment
with both ligands.
To analyze this colocalization, different regions of interest
corresponding to the endocytic vesicles were used, where
Manders’ coefficients values ranged from 0.91 to 0.96. These
results not only confirmed receptor cointernalization but also
showed the spatial dynamics of this phenomenon.
Since we detected colocalization of both receptors in the
same subcellular compartment, we next analyzed the possible
receptor heterodimerization by sensitized emission FRET
experiments in HEK293T cells. Firstly, images with cells
expressing only donor (H1R-CFP) or acceptor fluorophores
(H2R-YFP) were carried out to determine the donor and
acceptor Bleed-Through coefficients. FRET signals were
measured in cells coexpressing both receptors. All images
from three different experiments were analyzed with FRET
and Colocalization Analyzer plugin of ImageJ and represen-
tative images are shown. The software generated a FRET
image shown in Fig. 7 using the mean values of the donor
and acceptor Bleed-Through coefficients. In these images,
only the pixels that correspond to colocalization are shown.
Surprisingly, FRET signals were not detected at the plasma
membrane without stimulation, showing that no hetero-
dimerization occurs in basal conditions. However, high FRET
signals were observed in endocytic vescicles following H1R- or
H2R-agonist stimulation, suggesting stimulus-induced hetero-
dimerization when receptors are internalized. In Fig. 7, yellow
areas indicate high values of FRET whereas sky blue areas
indicate low values of FRET.
Overall, these results provide evidence that H1R and H2R
not only cointernalize following stimulation with H1 or H2
agonists but they also colocalize forming heterodimers in
endosomal vescicles.
H1R and H2R Crossdesensitization Is Not Dependent
on Receptors’ Cointernalization. In an attempt to de-
termine whether a direct cause-effect existed between re-
ceptor cointernalization and crossdesensitization we used
U937 derived clones (DC6, A2, and GB4) previously charac-
terized in our laboratory that exhibit blockade of H2R
internalization by different mechanisms. DC6 cell line was
obtained by stable transfection with a dynamin dominant
negative mutant which proved to dampen agonist-induced
H2R endocytosis (Fernandez et al., 2008). A2 cells have aGRK2
antisense construct that diminishes GRK2 expression levels
Fig. 7. Kinetics of ligand-induced H1R-
CFP and H2R-YFP heterodimerization
using FRET. The cellular distribution of
H1R-CFP (green) coexpressed with H2R-
YFP (red) in HEK293T cells was video-
recorded and is displayed on a single confo-
cal plane before (0 minutes) and after (5, 15,
and 25 minutes) stimulation with 10 mM
H1R agonist (A) or 10 mM H2R agonist (B).
The corresponding deduced FRET values
are shown with yellow and sky blue colors
corresponding to the maximum and min-
imum energy transfer, respectively. Inset
shows higher magnification of the area.
These images are representative of three
independent experiments. Scale bars,
10 mM.
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and diminishes both H2R desensitization and internalization
(Fernandez et al., 2002, 2011). GB4 expresses a GRK2
dominant negative mutant of the kinase site; in these cells
H2R internalization which depends on GRK2 kinase activity
was blocked but H2R desensitization proved to be enhanced
since it is mediated by the regulator of G protein-signaling
homology domain (RH) of GRK2 (Fernandez et al., 2011). As
shown in Fig. 8A, although H2R internalization stimulated by
the H1 agonist was abolished in all U937-derived clones, H2R
crossdesensitizationwas observed inDC6andGB4 cells. Similarly,
pretreatment of cells with the H2 agonist did not induce H1R
internalization in U937-derived clones but led to H1R cross-
desensitization in DC6 and GB4 clones (Fig. 8B). These
results clearly indicate that although both receptors
cointernalize, the inhibition of the internalization process
does not prevent receptor crossdesensitization.
On the other hand, crossdesensitization in GB4 cells was as
effective as in U937 cells, suggesting that GRK2-mediated
receptor phosphorylation is not necessary for H1R, and H2R
crossdesensitization. However, GRK2 kinase activity is re-
quired for receptors cointernalization as well as in H2R in-
ternalization mediated by its agonist. It is important to
point out that in the A2 clone the degree of both receptors’
crossdesensitization was significantly lower than in naïve
U937 cells, suggesting that the RH domain of GRK2 is re-
sponsible for H1R and H2R crossdesensitization.
Discussion
Given 1) the wide in vivo coexpression of histamine H1 and
H2 receptors, 2) the regulation between both receptors, and
3) the widespread prescription and over-the-counter sale of
ligands acting at H1 and H2 histamine receptors, the full
knowledge of the regulatory mechanisms underlying H1R
and H2R activation and their interplay is of high interest for
understanding current and designing novel therapeutic drugs.
Here, we present evidence of a H1R and H2R molecular
cross-regulation in endogenous and heterologous expressing
cells, which determines the ability of U937 cells to proliferate
under histamine treatment. The cross-regulation is evidenced
by a loss of responsiveness of H1R and H2R when cells were
exposed to a prolonged stimulus with either H2R or H1R
agonists, respectively.
It is generally accepted that heterologous desensitization
results from signaling pathways cross-talk involving activ-
ity changes in GPCRs, G proteins, or effectors where second
messenger-dependent protein kinases play a key role (Ferguson,
2001). However, in the present study, activation of AC, PLC,
PKA or PKC was not involved in H1R or H2R heterologous
desensitization in the cell types studied, but it was instead
mediated by GRK2, which in turn triggered cointernal-
ization of H1R/H2R complexes. GRK2 is a ubiquitous mem-
ber of the G protein-coupled receptor kinase (GRK) family
known to mediate GPCR homologous desensitization. The
overall topology of the members of the GRK family consist of
three well defined domains: 1) the conserved N-terminal
region involved in receptor recognition, which exhibits sequence
homology with RGS proteins (RH domain), 2) the central
domain, which is responsible for the kinase activity itself,
and 3) the poorly conserved C-terminal region that mediates
membrane targeting of the kinases and in the case of GRK2
encodes a pleckstrin homology domain. This kinase mediates
homologous desensitization of H1R and H2R as described by
Iwata et al. (2005) and Fernandez et al. (2011). However, in
recent years it has also been reported that GRK2 is involved
in GPCRs heterologous desensitization (Heijink et al., 2005,
Moulédous et al., 2012). In this way, cross-phosphorylation by
GRK2 is responsible for GPCRs crossdesensitization. Re-
markably, our findings show that in the case of H1R and H2R,
Fig. 8. Crossdesensitization and cross-internaliza-
tion in U937 derived clones. (A) U937, A2, DC6, and
GB4 cells were exposed (left) for 30 minutes to 10 mM
H1R agonist, washed, and cAMP response to 10 mM
amthamine determined, or (right) exposed for 60
minutes to 10 mM H1R agonist and [3H]tiotidine
saturation assays performed. Data represent the
percentage Bmax value fitted by nonlinear regression
of saturation assay. Data were calculated as the
mean 6 S.E.M. (n = 3). *P # 0.05; ***P # 0.001 with
respect to U937 cells. 100% corresponds to cAMP
response or [3H]tiotidine Bmax of unpretreated cells
(control). (B) U937, A2, DC6, and GB4 cells were
exposed (left) for 10 minutes to 10 mM H2R agonist,
washed, and cells then stimulated for 20 minutes
with 10 mM H1R agonist. InsP production was
measured as described under Materials and Meth-
ods. Alternatively, cells were exposed (right) for 60
minutes to 10 mMH2R agonist, and [3H]mepyramine
saturation assays were performed. Data represent
the percentage Bmax value fitted by nonlinear re-
gression of saturation assay. Data were calculated as
the mean6 S.E.M. (n = 3). ***P# 0.001 with respect
to U937 cells. 100% corresponds to InsP response or
[3H]tiotidine Bmax of unpretreated cells (control).
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GRK2-mediated receptor phosphorylation was not necessary
for H1R and H2R crossdesensitization but it played a crucial
role in receptor trafficking. On the other hand, considering
that RH domain of GRK2 is responsible for H1R and H2R
homologous desensitization and that the kinase activity of
GRK2 is not necessary for receptor crossdesensitization, it
would be expected that the RH domain of GRK2 mediates
H1R and H2R crossdesensitization.
Virtually all GPCRs undergo ligand-induced internal-
ization, a process originally considered as a mechanism
tending to remove desensitized receptors from the cell surface.
However, it is now well accepted that receptor endocytosis
serves a variety of purposes, including receptor down-
regulation, recycling, and relocalization of the cell signaling.
H1R agonist-induced internalization was described as a
mechanism involved in H1R regulation, although controver-
sial evidence exists regarding the dependence on clathrin
(Hishinuma et al., 2010) or caveolae/raft (Self et al., 2005).
Concerning H2R, we have previously reported that internal-
ization is part of receptor trafficking and crucial for the rapid
recovery of H2R-mediated cAMP response. Furthermore,
arrestin 3, dynamin, and clathrin are involved in both the
internalization and resensitization of the H2R (Fernandez
et al., 2008). Here, we evaluated as a mechanism of cross-
regulation the cross-internalization of H1R and H2R in CHO-
H1R-H2R and U937 cells based on the hypothesis that
a cross-talk between H1R and H2R regulates their signaling
capacity by modulating their internalization. Effectively, both
ligands were able to induce the internalization of both re-
ceptors, as supported by radioligand binding assays (Fig. 5)
and confocal microscopy in endogenously expressing and
H1R/H2R-transfected cells (Fig. 6). Although cointernaliza-
tion of H1R and H2R is not involved in their crossdesensitiza-
tion, it may regulate diverse processes such as receptor down
regulation, trafficking and recycling, and recruitment of scaf-
fold proteins that can initiate alternative signaling.
G protein-coupled receptors have classically been assumed
to exist and function as monomeric entities, and the paradigms
of ligand binding and signal transduction were based on
ligand/receptor/Gprotein 1:1:1 stoichiometry.However, a grow-
ing body of evidence indicates that some GPCRs can form both
homodimers and heterodimers. Although their existence is
now largely accepted (Angers et al., 2002; George et al., 2002)
their functional importance remains more enigmatic and in
some cases even controversial. Recent studies confirmed that
monomeric signaling of GPCRs is possible and occurs with
physiologic speed indicating that it is not necessary for GPCRs to
dimerize to execute their basic function of transducing a signal
from ligand binding toGprotein activation (Whorton et al., 2008).
However, the possibility of GPCR dimer formation is now
widely accepted, and concerning the functional consequences
of GPCR oligomerization, important questions remain un-
resolved. In some cases, oligomerization has been shown to
have a primary role in receptor maturation allowing the
correct transport of receptors from the endoplasmic reticulum
to the cell surface. Once at the plasma membrane, oligomers
might become the target for dynamic regulation by ligand
binding. It has been proposed that GPCR heterodimerization
leads to both positive and negative ligand binding coopera-
tivity as well as potentiating or attenuating signaling, or
changing G protein selectivity (Breitwieser, 2004; Terrillon
and Bouvier, 2004). Several studies have suggested that
heterodimerization may affect agonist-promoted GPCR en-
docytosis. For many reported heterodimers, stimulation of
only one of the receptors was sufficient to promote coin-
ternalization of the entire dimer (Rocheville et al., 2000;
Stanasila et al., 2003; Xu et al., 2003). Moreover, for SSTR2A
somatostatin/opioid and for A2A adenosine/D2 dopamine re-
ceptors, the reported cointernalization was associated with
signaling crossdesensitization (Hillion et al., 2002; Pfeiffer
et al., 2002).
In our study using a heterologous expression system with
receptors fused to fluorescent proteins we observed that both
receptors colocalized approximately 60% on cell membrane
and cointernalized when one is stimulated. Receptor di-
merization was not detected on basal conditions, but there
was a strong FRET signal when agonist-induced receptor
cointernalization occurred. These results suggest that di-
merization is not involved in receptor maturation or trans-
port to the cell surface or alteration of ligand binding but it
may play a role in the regulation of their trafficking and/or
signaling within the cells after receptors are cointernalized.
It is well established that once internalized, receptors can
initiate additional, G protein-independent signaling path-
ways such as a b-arrestin-mediated coupling to mitogen-
activated protein kinases (Kovacs et al., 2009). Therefore,
further investigations will provide a better understanding of
the role of H1R and H2R dimerization in their signaling. The
disruption of dimerization would be an interesting tool to
clarify the role and function of these heterodimers. In this
context, in the last few years, great efforts have been made
to develop small-molecule ligands specific for these com-
plexes, as bivalent ligands (agonist or antagonist), mono-
valent “drug-like” heterodimer-specific compounds, and
interface disrupting compounds (Filizola, 2010). Discovering
small-molecule drugs that inhibit protein-protein interac-
tions is an emerging but still very challenging area in drug
design. On the other hand, several computational and
mutagenesis strategies are developing to study GPCR
interactions and have predicted TM1, TM4, and/or TM5 as
likely dimerization/oligomerization contact interfaces of
GPCRs. The study of the interacting domains of H1R and
H2R would be of great interest for evaluating the function-
ality of the dimer formation in the signaling of both
receptors and eventually for identifying novel pathways for
drug discovery.
While these studies were performed in heterologous expres-
sion systems, these results were confirmed when the studies
were carried out in U937 cells which express H1R and H2R
endogenously. This cross-regulation has profound consequences
on cell fate, since the exposure to H1-agonist ligand alone or in
combination with specific H2 agonist, ultimately determines
whether cells proliferate, arrest their cell cycle, or engage with
apoptotic processes.
GPCR heterodimerization constitutes a new level of cross-
talk that bears a priori unpredictable consequences, although
with great potential clinical relevance. It has been suggested
that impairment of dimers between angiotensin AT1 and
bradykinin B2 receptors is related to preeclampsia and some
forms of hypertension in experimental models (AbdAlla et al.,
2005). Furthermore, dimerization of b2 adrenergic and PGE2
receptors decreases bronchodilating response of b2 agonists,
diminishing the efficacy of asthma treatments (McGraw et al.,
2006).
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The fact that H1 and H2 receptors mutually desensitize
each other, and cross-internalize forming heterodimers, pro-
vides now a key process determining cellular fate in response to
H1R and H2R agonists. It can be speculated that in tissues
where both receptors are coexpressed the regulatory mecha-
nism described herein could have profound consequences on
histamine response.
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